Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trialLisa A. Beck, Amy S. Paller, Hidehisa Saeki et al.|Journal of the American Academy of Dermatology|2022Cited by 51